Sunday July 21, 2019

Weekly Social Hour is all you Need to Help Dementia Patients

Nearly 70% people living in care homes suffer from dementia, so it is only fair that the staff in the care homes have the right training to provide good quality dementia care

0
//
Dementia
Dementia treatment. Wikimedia
  • Person-centred activities combined with just one hour a week of social interaction will be very helpful for people with dementia living in care homes
  • This trial was conducted with more than 800 participants living with dementia across 69 care homes in South London, North London and Buckingham-shire
  • Also, this particular approach saved money in comparison with the standard care

Washington DC, July 17, 2017: According to a recent survey, quality of life can be improved and agitation can be reduced, while saving money, for people with dementia living in care homes with the help of person-centred activities combined with just one hour a week of social interaction.

The University of Exeter, King’s College London and Oxford Health NHS Foundation Trust led the findings from a large-scale trial that were presented at the Alzheimer’s Association International Conference 2017 (AAIC).

This trial was conducted with more than 800 participants living with dementia across 69 care homes in South London, North London and Buckingham-shire. The study involved two ‘care staff champions’ at each home who were trained over four day-long sessions, to take simple measures that such as involve talking to residents about their interests and decisions around their own care. When combined with just one hour a week of social interaction, it improved quality of life and reduced agitation.

ALSO READAnger Issues? 8 Ways to Get Done With it Now !

Also, this particular approach saved money in comparison with the standard care. Researchers believe that the next key challenge is to roll the programme to the 28,000 care homes in the UK that will benefit the lives of the 300,000 people with dementia living in these facilities.

According to ANI report, the lead researcher in the project, Clive Ballard said that people with dementia who are living in care homes can be considered among the most vulnerable in our society. “Incredibly, of 170 carer training manuals available on the market, only four are based on evidence that they really work. Our outcomes show that good staff training and just one hour a week of social interaction significantly improves quality of life for a group of people who can often be forgotten by society,” she added.

Doug Brown, Director of Research for Alzheimer’s Society, feels that 70% of people living in care homes suffer from dementia. That is why it is necessary for the staff to have the right training to provide the best quality dementia care.

– prepared by Durba Mandal of NewsGram. Twitter @dubumerang

Next Story

Artificial Intelligence Can Prove to be a Boon for Patients with Alzheimer’s

The findings demonstrated the potential valid clinical utility of “MemTrax”, administered as part of the online test in screening for variations in cognitive brain health

0
A lady suffering from Alzheimer's. Flickr

Artificial Intelligence (AI) can prove to be essential for healthcare providers to detect and manage Alzheimer’s disease or a related form of dementia, from which 44 million people suffer worldwide.

In the study published in the Journal of Alzheimer’s Disease, the team introduced supervised Machine Learning (ML) as a modern approach and new value-added complementary tool in cognitive brain health assessment and related patient care and management.

With the increasingly favourable instrument “MemTrax” — an online memory test using image recognition — the clinical efficacy of this new approach as a memory function screening tool has been sufficiently demonstrated.

For the study, a team of researchers including from the Florida Atlantic University, SIVOTEC Analytics and Stanford University employed a novel application of supervised ML and predictive modeling to demonstrate and validate the cross-sectional utility of “MemTrax” as a clinical decision support screening tool for assessing cognitive impairment.

"The question for us now is not how to eliminate cholesterol from the brain, but about how to control cholesterol's role in Alzheimer's disease through the regulation of its interaction with amyloid-beta," Vendruscolo said.
In Alzheimer’s disease, patients start losing memory. Pixabay

The findings demonstrated the potential valid clinical utility of “MemTrax”, administered as part of the online test in screening for variations in cognitive brain health.

“Findings from our study provide an important step in advancing the approach for clinically managing a very complex condition like Alzheimer’s disease,” said lead author Michael F. Bergeron, Senior Vice President, SIVOTEC Analytics.

Also Read: Facebook Develops VR Avatars with Real-time Interactivity

“By analysing a wide array of attributes across multiple domains of the human system and functional behaviours of brain health, informed and strategically directed advanced data mining, supervised Machine Learning, and robust analytics can be integral for healthcare providers to detect and anticipate further progression in this disease and myriad other aspects of cognitive impairment,” he explained. (IANS)